These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 35125737)
21. Immediate postplacental insertion and fixation of the CuFix postpartum implant system. Van Kets H; Parewijck W; Van der Pas H; Batar I; Creatsas G; Koumantakis K; Thiery M Contraception; 1993 Oct; 48(4):349-57. PubMed ID: 8222662 [TBL] [Abstract][Full Text] [Related]
22. Post-placental Intrauterine Device Insertion Versus Delayed Intrauterine Device Insertion: An Observational Study. Khurshid N; Taing S; Qureshi A; Jan Khanyari I J Obstet Gynaecol India; 2020 Apr; 70(2):145-151. PubMed ID: 32255953 [TBL] [Abstract][Full Text] [Related]
23. Do insertion-related problems affect subsequent IUD performance? Chi IC; Waszak CS; Wilkens LR Contraception; 1986 Nov; 34(5):497-503. PubMed ID: 3816233 [TBL] [Abstract][Full Text] [Related]
24. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception. Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577 [TBL] [Abstract][Full Text] [Related]
25. Impact of immediate postabortal insertion of intrauterine contraception on repeat abortion. Goodman S; Hendlish SK; Reeves MF; Foster-Rosales A Contraception; 2008 Aug; 78(2):143-8. PubMed ID: 18672116 [TBL] [Abstract][Full Text] [Related]
26. Non-visualisation of strings after postplacental insertion of Copper-T 380A intrauterine device. Dewan R; Dewan A; Singal S; Bharti R; Kaim M J Fam Plann Reprod Health Care; 2017 Jul; 43(3):186-194. PubMed ID: 27207850 [TBL] [Abstract][Full Text] [Related]
27. Can intrauterine device removals for bleeding or pain be predicted at a one-month follow-up visit? A multivariate analysis. Stanback J; Grimes D Contraception; 1998 Dec; 58(6):357-60. PubMed ID: 10095972 [TBL] [Abstract][Full Text] [Related]
29. One-year clinical experience with FlexiGard. Batar I Contraception; 1992 Oct; 46(4):307-12. PubMed ID: 1486769 [TBL] [Abstract][Full Text] [Related]
30. Society of Family Planning Guidelines: Postplacental insertion of intrauterine devices. Whitaker AK; Chen BA Contraception; 2018 Jan; 97(1):2-13. PubMed ID: 28987293 [TBL] [Abstract][Full Text] [Related]
31. Risk factors for postpartum intrauterine device expulsion among women delivering at a tertiary Hospital in Uganda: a prospective cohort study. Muhumuza J; Migisha R; Ngonzi J; Kayondo M; Mugyenyi G Contracept Reprod Med; 2021 Mar; 6(1):7. PubMed ID: 33648587 [TBL] [Abstract][Full Text] [Related]
32. Performance of copper intrauterine devices when inserted after an expulsion. Bahamondes L; Díaz J; Marchi NM; Petta CA; Cristofoletti ML; Gomez G Hum Reprod; 1995 Nov; 10(11):2917-8. PubMed ID: 8747044 [TBL] [Abstract][Full Text] [Related]
33. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls. Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S; Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014 [TBL] [Abstract][Full Text] [Related]
34. Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices. Woo I; Seifert S; Hendricks D; Jamshidi RM; Burke AE; Fox MC Contraception; 2015 Dec; 92(6):532-5. PubMed ID: 26408376 [TBL] [Abstract][Full Text] [Related]
35. Current status of frameless anchored IUD for immediate intracesarean insertion. Wildemeersch D; Goldstuck ND; Hasskamp T Dev Period Med; 2016; 20(1):7-15. PubMed ID: 27416620 [TBL] [Abstract][Full Text] [Related]
36. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study. Sivin I; el Mahgoub S; McCarthy T; Mishell DR; Shoupe D; Alvarez F; Brache V; Jimenez E; Diaz J; Faundes A Contraception; 1990 Oct; 42(4):361-78. PubMed ID: 2124179 [TBL] [Abstract][Full Text] [Related]
37. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system. Suvisaari J; Lähteenmäki P Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872 [TBL] [Abstract][Full Text] [Related]
38. A collaborative study of the progesterone intrauterine device (Progestasert). The World Health Organization Task Force on Methods for the Regulation of Implantation. Newton J; Szontagh F; Lebech P; Rowe P Contraception; 1979 Jun; 19(6):575-89. PubMed ID: 487808 [TBL] [Abstract][Full Text] [Related]
39. [Copper-7 intrauterine device (Gravigard). Report of experience]. Jürgensen O; Stenzel I; Wirth A; Sina D; Taubert HD Fortschr Med; 1976 Mar; 94(9):515-21. PubMed ID: 964914 [TBL] [Abstract][Full Text] [Related]
40. Twelve-month comparative multicenter study of the TCu 380A and ML 250 intrauterine devices in Bangkok, Thailand. Reinprayoon D; Gilmore C; Farr G; Amatya R Contraception; 1998 Oct; 58(4):201-6. PubMed ID: 9865999 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]